Orexin receptor 2 (OX2R) agonist for use in narcolepsy type 1 (NT1)

CA3329043A1Undetermined Publication Date: 2025-11-06TAKEDA PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CA3329043
Authority / Receiving Office
CA · CA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-04-30
Filing Date
2025-04-30
Publication Date
2025-11-06
Patent Text Reader

Abstract

Disclosed herein are methods, uses and composition for treating narcolepsy with cataplexy (narcolepsy type 1 or NT1), blunted nocturnal blood pressure dip in a subject having narcolepsy type 1 or cognitive impairment in a subject having narcolepsy type 1, by administering an orexin receptor 2 agonist to the subject at one or more daily dosages.
Need to check novelty before this filing date? Find Prior Art